Evaluating the impact of specialty pharmacies on access to biologics in patients with moderate-to-severe asthma
Specialty pharmacy implementation significantly accelerated approval and showed a trend toward faster treatment initiation. Delays in administration persisted despite adjustment for patient-level factors, underscoring the role of other barriers. Larger, multi-center studies are warranted.
Authors
- Nitza Granados
- Kevin P. Fiori (ORCID: https://orcid.org/0000-0003-1370-7366)
- Adam Haines (ORCID: https://orcid.org/0000-0002-1002-3324)
- Thomas Scharfenberger
- S. P. Jariwala
- Xiaojia Wang
- Ananna Kazi
- Lakshmi Mahajan
- Rachel Berglas
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
- Columbia University Irving Medical Center (US)
- Presbyterian Hospital (US)
- Montefiore Hospital (GB)
Publication Details
- Journal
- Journal of Asthma
- Published
- 2026-02-18
- DOI
- https://doi.org/10.1080/02770903.2026.2633363
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00